Background: Adjuvant chemotherapy is required following the resection of aggressive
NSCLC. It is therefore necessary to identify factors that accurately predict prognosis …

Objective: Dysadherin is a cancer-associated cell membrane glycoprotein that has been
reported to downregulate E-cadherin expression and promote metastasis. To evaluate the …

Dysadherin is a recently characterized cancer-associated cell membrane glycoprotein that
has a crucial role to cell-cell adhesiveness. The aim of this study was to examine dysadherin …

A novel glycoprotein, dysadherin, has an anti-cell–cell adhesion function through
downregulating E-cadherin. In this study, we investigated the expressions of dysadherin and …

Dysadherin, a cancer associated cell membrane glycoprotein, has been reported to
downregulate E-cadherin. Aberrant expression of Ecadherin has been associated with the …

OBJECTIVE: The aim of this study was to evaluate the expression of dysadherin and E-
cadherin and to investigate their clinical significance as prognostic factors in non–small cell …

The protein and mRNA expression of dysadherin was studied in a series of squamous cell
cervical carcinomas, and their clinicopathological associations and prognostic value were …

The E-cadherin-mediated cell adhesion system is frequently inactivated by multiple
mechanisms and is involved in tumor progression in many types of cancer. Recently we …

Background: The aim of this study was to evaluate the impact of dysadherin and E-cadherin
expression on the clinical outcomes, including the treatment outcomes and recurrence …

Purpose: Dysadherin, a cancer-associated cell membrane glycoprotein, has been reported
to down-regulate E-cadherin expression and promote metastasis. To evaluate the role of …